ACGT Presents ‘Achieving Cancer Remission with Cell and Gene Therapies’

World-class Research Fellows and Physicians to Present at the Harvard Club Oct.15

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

Alliance for Cancer Gene Therapy (ACGT)

New York, NY and Stamford, CT (PRWEB) October 11, 2013

Alliance for Cancer Gene Therapy (ACGT), a not-for-profit dedicated exclusively to funding research for cancer treatments using cell and gene therapies, will host “Achieving Cancer Remission with Cell and Gene Therapies” on Tuesday, October 15 at the Harvard Club of New York City, 35 W. 44th Street. ACGT is renowned for devoting 100-percent of funds raised directly to research, and for uniting top scientific minds to explore innovative treatments that target only the cancer.

Featuring a panel of esteemed ACGT research fellows and award-winning doctors from the nation’s top medical institutions, the evening will focus on the extraordinary potential of cell- and gene-based therapies to provide swift and safe treatment of all types of cancer.

“Our October event will bring together top cancer researchers in the cell and gene therapy field, and showcase the remarkable promise of the treatments,” said Barbara Netter, co-founder of the Stamford, CT-based ACGT. Mrs. Netter and her husband Edward created the non-profit in 2001, shortly after losing their daughter-in-law to breast cancer.

The panel will be hosted by Dr. Savio L.C. Woo, chairman of the ACGT Scientific Advisory Council and Professor and Founding Chairman of the Department of Gene and Cell Medicine at Mt. Sinai School of Medicine in New York. Dr. Woo has served as chairman for a slate of non-profit gene therapy organizations and been awarded a suite of prestigious awards for his research. Dr. Woo – along with Dr. Michael Lotze of the University of Pittsburgh – introduced Edward and Barbara Netter to the possibilities of gene and cell therapy over one decade ago.

The evening will begin with a reception at 6:30 p.m., followed by a salutation by Dr. Savio Woo at 7:15 p.m. The presentation will start at 7:30 p.m., and culminate with a question and answer session at 8:30 p.m.

Panel members include:

  •     Laurence Cooper, M.D., Ph.D. at M.D. Anderson Cancer Center. 2003 ACGT Young Investigator Award
  •     Carl H. June, M.D. at University of Pennsylvania. 2004 ACGT Gene Therapy for Lymphoma & Leukemia Award; 2008 The Joan Miller & Linda Bernstein ACGT Gene Therapy Ovarian Cancer Award
  •     Michel Sadelain, M.D., Ph.D. at Memorial Sloan-Kettering Cancer Center. 2004 ACGT Gene Therapy for Lymphoma & Leukemia Award.

(For further information on the evening’s panelists, please see bios at the end of the release.)

The presentation “Achieving Cancer Remission with Cell and Gene Therapies” is free and open to the public, although reservations are limited. For additional information or to make a reservation, contact Betty Condon at 203.358.8000, ext. 497 or bcondon(at)acgtfoundation(dot)org.

ACGT is located at 96 Cummings Point Road, Stamford, CT 06902.

About Alliance for Cancer Gene Therapy (ACGT)
Established in 2001, ACGT (http://www.acgtfoundation.org) is the nation’s only not-for-profit exclusively dedicated to cancer cell and gene therapy treatments for all types of cancer. One-hundred percent of contributions go directly to research. ACGT has funded 42 grants in the U.S. and Canada since its founding in 2001 by Barbara Netter and her late husband, Edward, to conduct and accelerate critically needed innovative research for all types of cancer. ACGT’s Scientific Advisory Council is comprised of 16 of the nation’s most distinguished physicians and researchers in cell and gene therapy, who thoroughly review all grants. Since its inception, ACGT has awarded 27 grants to Young Investigators and 15 grants to Clinical Investigators, totaling $24.2 million in funding. Barbara Netter, as President, together with other members of the Board of Directors, are fully committed to ACGT’s continued support of this critically needed innovative research.


Contact

  • Kat McKee
    Co-Communications, Inc.
    +1 914-666-0066
    Email
  • Kevin Zawacki
    Co-Communications, Inc.
    914-666-0066
    Email